Popular on TelAve
- Wellness Technology Distributor Helping People Set Up Wellness Center Businesses - 325
- TechHouse Earns Highly Selective Microsoft Support Badge - 312
- ParkLens Launches AI-Powered Parking Sign Decoder to Help Drivers Avoid Costly Parking Tickets - 293
- Curious About Mensa? DFW Event Offers a 1-Day Immersion - 271
- How Strategic WooCommerce Development and Digital Marketing Helped a Fashion Ecommerce Business Increase Revenue by 3X - 236
- USA Med Bed Helping Home Care Patients with Refurbished Hill Rom Hospital Beds - 184
- Dr. Stephen Shainbart Launches Expanded Mental Health Support for Anxiety and Depression in Toronto - 103
- West Virginia Leaders Announce Support for Election Integrity Network's Model Election Laws Handbook
- Community, Conservation & Waterwise Inspiration Bloom on June 6
- RADIUS Conference Returns with More Partners and New Speakers
Similar on TelAve
- Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc
- Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
- FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
- Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
- Medical Experts Highlight the Importance of Second Opinions in Death Investigations
- NRx Pharmaceuticals (N A S D A Q: NRXP) Accelerates Into National Spotlight as Manufacturing Launch, Federal Policy & AI-Driven Breakthroughs Converge
- More Life Summit 2026 Announces Gary Brecka & Mr. Olympia Derek Lunsford as First Speakers for Miami Event
- Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
- Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
- AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
PurMa Biologics Publishes Free Mycoplasma Detection Protocol for Cell Culture Researchers
TelAve News/10899036
Oklahoma City biotech company releases step-by-step mycoplasma detection and elimination protocol
OKLAHOMA CITY - TelAve -- OKLAHOMA CITY, OK — PurMa Biologics, a leading manufacturer of cell culture reagents and biologics services, has published a comprehensive mycoplasma detection and elimination protocol available free to the scientific community via protocols.io.
Mycoplasma contamination is estimated to affect up to 35% of cell cultures worldwide, making it one of the most significant threats to research reproducibility and integrity. Left undetected, mycoplasma can alter cell behavior, gene expression, and experimental results, leading to costly research failures.
The protocol, developed by PurMa Biologics' team of scientists with over 30 years of combined expertise in cell culture and protein biochemistry, outlines a clear 5-step process for detecting and eliminating mycoplasma contamination using validated reagents.
"We want to give researchers the tools and knowledge they need to maintain clean, reliable cell cultures," said Seifollah Azadi, Founder and CEO of PurMa Biologics. "This protocol is part of our commitment to supporting the scientific community beyond just supplying reagents."
More on TelAve News
PurMa Biologics offers over 3,000 cell culture reagents including culture media, buffers, serums, trypsin, transfection reagents, and mycoplasma detection and elimination kits. The company also provides custom biotech services including monoclonal antibody development, protein expression and purification, and gene cloning.
The free protocol is available at: http://www.protocols.io/workspaces/purma-biologics
For more information about PurMa Biologics and their full catalog of cell culture reagents, visit http://www.purmabiologics.com or call 1-866-720-6116.
About PurMa Biologics:
PurMa Biologics is an Oklahoma City-based biotechnology company specializing in cell culture reagents and biologics services. With over 30 years of combined expertise, PurMa Biologics serves research institutions, biotechnology companies, and laboratories worldwide with 3,000+ high-quality reagents and custom research services.
Mycoplasma contamination is estimated to affect up to 35% of cell cultures worldwide, making it one of the most significant threats to research reproducibility and integrity. Left undetected, mycoplasma can alter cell behavior, gene expression, and experimental results, leading to costly research failures.
The protocol, developed by PurMa Biologics' team of scientists with over 30 years of combined expertise in cell culture and protein biochemistry, outlines a clear 5-step process for detecting and eliminating mycoplasma contamination using validated reagents.
"We want to give researchers the tools and knowledge they need to maintain clean, reliable cell cultures," said Seifollah Azadi, Founder and CEO of PurMa Biologics. "This protocol is part of our commitment to supporting the scientific community beyond just supplying reagents."
More on TelAve News
- Prince George's County Students Now Have A Rare Opportunity In TV Film Production Career-readiness
- City of San José Could Lose Access to Millions Under New CalEnviroScreen Tool 5.0
- This Weekend Causeway Cove Country BBQ & Music Festival Returns for Fourth Year, Celebrating America's 250th Anniversary on the Water
- Webtronix Designs Web Agency Launches "LocalFind" to Revolutionize AI Local SEO for Local Businesses
- Christmas Miracle Chronicles - New movie coming up this holiday season !
PurMa Biologics offers over 3,000 cell culture reagents including culture media, buffers, serums, trypsin, transfection reagents, and mycoplasma detection and elimination kits. The company also provides custom biotech services including monoclonal antibody development, protein expression and purification, and gene cloning.
The free protocol is available at: http://www.protocols.io/workspaces/purma-biologics
For more information about PurMa Biologics and their full catalog of cell culture reagents, visit http://www.purmabiologics.com or call 1-866-720-6116.
About PurMa Biologics:
PurMa Biologics is an Oklahoma City-based biotechnology company specializing in cell culture reagents and biologics services. With over 30 years of combined expertise, PurMa Biologics serves research institutions, biotechnology companies, and laboratories worldwide with 3,000+ high-quality reagents and custom research services.
Source: PurMa Biologics
0 Comments
Latest on TelAve News
- Finland Sets Casino Gambling Risk Limits at 2% of Income, 4 Days, 2 Game Types
- The Prolific Writer, Producer "Hunter" Is Bringing New Music For Summer Release
- Millennial Maven Creative Foundation Assists In Bringing Juneteenth to the FIFA World Cup Fan Festival with an Authentically Dallas Lineup
- Two Florida Family Law Firms Named Among the State's Best Divorce Practices for 2026
- Tacoma Arts Live And Accelerating Creative Enterprise Present Ace Showace
- George Martinez Launches Community Re-distribution Initiative With Donation to the Gamma Alpha Alpha Chapter of Omega Psi Phi Fraternity, Inc
- SITE Technologies Releases Industry Research Report Exposing the CapEx Intelligence Gap in Commercial Real Estate
- A Business Novel About Ambition, Ethics, and the Hidden Realities of International Business
- Century Fasteners Corp. Exhibiting at 2026 Farnborough International Airshow
- Compton to host first Juneteenth celebration with We Are Us Festival
- DuoKey Launches Quantum Risk Score to Help Enterprises Prioritise Post-Quantum Cryptography Migration
- Top 5 Most Reliable Used Vans in the UK in 2026
- Dominican Fashion Designer Raiza Bonaparte presents the Sovereign Despampanante Collection at the Library of Congress
- What Happens When Congress Says No? New Book Examines the Boland Amendments, Iran-Contra Affair & Jamaican Posse, as US Congress Debate Over Military
- Warm, Dry Summer Forecast Points to a Stronger Wasp and Yellowjacket Season Across the Pacific Northwest
- Qscription Technologies Appoints Anurag Velekkatt Sunil Kumar to Drive Enterprise Scale
- SafeBets Named Presenting Sponsor of IMCX 2026, Bringing Its No-Deposit Prediction Platform to the Creator Economy's Deal-Making Conference
- A New Pulse for Cardiac Care in Baltimore: St. Elizabeth Rehab & Nursing Welcomes Dr. Hakim Uqdah and Expands Advanced Heart Program
- Inframark–Slater Joint Venture Selected to Manage Fulton County Wastewater Operations
- Cancun International Airport Reports Strong Start to Summer 2026 Travel Season